Caelyx as Primary Treatment for Patients With Breast Cancer and a History of Heart Disease and/or Age Over 65 Years
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: Liposomal pegylated doxorubicine
Sponsor: SOLTI Breast Cancer Research Group
Collaborators: Schering-Plough